Variations in COVID-19 vaccination uptake among people in receipt of psychotropic drugs: cross-sectional analysis of a national population-based prospective cohort by Murphy, S, O'Reilly, D, Owen, RK, Akbari, A, Lowthian, E, Bedston, S, Torabi, F, Beggs, J, Chuter, A, de Lusignan, S, Hobbs, R, Robertson, C, Katikireddi, SV, Sheikh, A, Bradley, DT

COVID-19 booster vaccination uptake and infection breakthrough amongst health care workers in Wales: a national prospective cohort study by Bedston, S, Lowthian, E, Jarvis, CI, Akbari, A, Beggs, J, Bradley, D, de Lusignan, S, Griffiths, R, Herbert, L, Hobbs, R, Kerr, S, Lyons, J, Midgley, W, Owen, RK, Quint, JK, Tsang, R, Torabi, F, Sheikh, A, Lyons, RA

Uptake of COVID-19 vaccinations amongst 3,433,483 children and young people: meta-analysis of UK prospective cohorts by Aldridge, SJ, Agrawal, U, Murphy, S, Millington, T, Akbari, A, Almaghrabi, F, Anand, SN, Bedston, S, Goudie, R, Griffiths, R, Joy, M, Lowthian, E, de Lusignan, S, Patterson, L, Robertson, C, Rudan, I, Bradley, DT, Lyons, RA, Sheikh, A, Owen, RK

Adverse events following first and second dose COVID-19 vaccination in England, October 2020 to September 2021: a national vaccine surveillance platform self-controlled case series... by Tsang, RSM, Joy, M, Byford, R, Robertson, C, Anand, SN, Hinton, W, Mayor, N, Kar, D, Williams, J, Victor, W, Akbari, A, Bradley, DT, Murphy, S, O'Reilly, D, Owen, RK, Chuter, A, Beggs, J, Howsam, G, Sheikh, A, Hobbs, FDR, de Lusignan, S

Adverse events after first and second doses of COVID-19 vaccination in England: a national vaccine surveillance platform self-controlled case series study by Tsang, RS, Agrawal, U, Joy, M, Byford, R, Robertson, C, Anand, SN, Hinton, W, Mayor, N, Kar, D, Williams, J, Victor, W, Akbari, A, Bradley, DT, Murphy, S, O’Reilly, D, Owen, RK, Chuter, A, Beggs, J, Howsam, G, Sheikh, A, Richard Hobbs, F, Lusignan, SD

Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in Englan... by Agrawal, U, Bedston, S, McCowan, C, Oke, J, Patterson, L, Robertson, C, Akbari, A, Azcoaga-Lorenzo, A, Bradley, DT, Fagbamigbe, AF, Grange, Z, Hall, ECR, Joy, M, Katikireddi, SV, Kerr, S, Ritchie, L, Murphy, S, Owen, RK, Rudan, I, Shah, SA, Simpson, CR, Torabi, F, Tsang, RSM, de Lusignan, S, Lyons, RA, O'Reilly, D, Sheikh, A

Risk of thrombocytopenic, haemorrhagic and thromboembolic disorders following COVID-19 vaccination and positive test: a self-controlled case series analysis in Wales by Torabi, F, Bedston, S, Lowthian, E, Akbari, A, Owen, RK, Bradley, DT, Agrawal, U, Collins, P, Fry, R, Griffiths, LJ, Beggs, J, Davies, G, Hollinghurst, J, Lyons, J, Abbasizanjani, H, Cottrell, S, Perry, M, Roberts, R, Azcoaga-Lorenzo, A, Fagbamigbe, AF, Shi, T, Tsang, RSM, Robertson, C, Hobbs, FDR, de Lusignan, S, McCowan, C, Gravenor, M, Simpson, CR, Sheikh, A, Lyons, RA

First dose ChAdOx1 and BNT162b2 COVID-19 vaccinations and cerebral venous sinus thrombosis: a pooled self-controlled case series study of 11.6 million individuals in England, Scotl... by Kerr, S, Joy, M, Torabi, F, Bedston, S, Akbari, A, Agrawal, U, Beggs, J, Bradley, D, Chuter, A, Docherty, AB, Ford, D, Hobbs, R, Katikireddi, SV, Lowthian, E, de Lusignan, S, Lyons, R, Marple, J, McCowan, C, McGagh, D, McMenamin, J, Moore, E, Murray, J-LK, Owen, RK, Pan, J, Ritchie, L, Shah, SA, Shi, T, Stock, S, Tsang, RSM, Vasileiou, E, Woolhouse, M, Simpson, CR, Robertson, C, Sheikh, A